Filing Details
- Accession Number:
- 0001209191-19-056481
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 19:07:26
- Reporting Period:
- 2019-11-13
- Accepted Time:
- 2019-11-13 19:07:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645666 | Kezar Life Sciences Inc. | KZR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1382629 | Marc Belsky | C/O Kezar Life Sciences, Inc. 4000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-13 | 800 | $2.76 | 2,000 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
Footnotes
- The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.74 to $2.77 on November 13, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.